Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
27%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
HRTS
43
HOLDINGS
23%
ALSO IN THNR
THNR
20
HOLDINGS
50%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in HRTS |
Weight in THNR |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 7.8% | 11.4% | 7.8% | |
ABBVIE INC | 3.5% | 5.7% | 3.5% | |
GILEAD SCIENCES INC | 3.4% | 5.3% | 3.4% | |
MERCK & CO. INC. | 2.6% | 5.5% | 2.6% | |
AMGEN INC | 2.5% | 6.8% | 2.5% |
HRTS Overweight Relative to THNR
ABBOTT LABORATORIES | 4.7% | |
UNITEDHEALTH GROUP INC | 4.6% | |
ASTRAZENECA PLC | 4.5% | |
ROCHE HOLDINGS LTD-SPONS ADR | 4.2% | |
BOSTON SCIENTIFIC CORP | 3.9% | |
NOVO NORDISK A/S-B | 3.5% | |
THERMO FISHER SCIENTIFIC INC | 3.4% | |
NOVARTIS AG | 3.3% | |
MEDTRONIC PLC | 3.0% | |
BRIDGEBIO PHARMA, INC. | 2.9% |
HRTS Underweight Relative to THNR
NOVO-NORDISK A/S-SPONS ADR | -9.1% | |
REGENERON PHARMACEUTICALS | -5.6% | |
ASTRAZENECA PLC-SPONS ADR | -5.6% | |
PFIZER INC | -5.4% | |
INNOVENT BIOLOGICS, INC. | -5.2% | |
ROCHE HOLDING LTD | -5.0% | |
CHINA PHARMACEUTICAL GROUP | -4.9% | |
SHIONOGI & CO LTD | -4.3% | |
AMGEN INC | -4.3% | |
CHUGAI PHARMACEUTICAL CO LTD | -3.8% |